Hendershot Investments Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Hendershot Investments Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $10.1 Million - $11.9 Million	-17,010 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$543.48 - $670.97 $33,695 - $41,600	-62 Reduced 0.36%	17,010 $10.7 Million
Q3 2021 Oct 26, 2021	BUY	$574.03 - $680.96 $155,562 - $184,540	271 Added 1.61%	17,072 $10.3 Million
Q2 2021 Jul 28, 2021	BUY	$472.8 - $558.54 $575,397 - $679,743	1,217 Added 7.81%	16,801 $9.38 Million
Q1 2021 May 03, 2021	BUY	$446.73 - $548.2 $2.47 Million - $3.03 Million	5,527 Added 54.96%	15,584 $7.37 Million
Q4 2020 Jan 25, 2021	BUY	$478.3 - $607.98 $4.81 Million - $6.11 Million	10,057 New	10,057 $4.86 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hendershot Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Hendershot Investments Inc. with notifications on news.